Correlation Between Apogee Therapeutics, and Silence Therapeutics
Can any of the company-specific risk be diversified away by investing in both Apogee Therapeutics, and Silence Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apogee Therapeutics, and Silence Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apogee Therapeutics, Common and Silence Therapeutics PLC, you can compare the effects of market volatilities on Apogee Therapeutics, and Silence Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apogee Therapeutics, with a short position of Silence Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apogee Therapeutics, and Silence Therapeutics.
Diversification Opportunities for Apogee Therapeutics, and Silence Therapeutics
0.65 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Apogee and Silence is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Apogee Therapeutics, Common and Silence Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Silence Therapeutics PLC and Apogee Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apogee Therapeutics, Common are associated (or correlated) with Silence Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Silence Therapeutics PLC has no effect on the direction of Apogee Therapeutics, i.e., Apogee Therapeutics, and Silence Therapeutics go up and down completely randomly.
Pair Corralation between Apogee Therapeutics, and Silence Therapeutics
Given the investment horizon of 90 days Apogee Therapeutics, Common is expected to generate 0.38 times more return on investment than Silence Therapeutics. However, Apogee Therapeutics, Common is 2.63 times less risky than Silence Therapeutics. It trades about -0.23 of its potential returns per unit of risk. Silence Therapeutics PLC is currently generating about -0.34 per unit of risk. If you would invest 5,449 in Apogee Therapeutics, Common on September 2, 2024 and sell it today you would lose (934.00) from holding Apogee Therapeutics, Common or give up 17.14% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Apogee Therapeutics, Common vs. Silence Therapeutics PLC
Performance |
| Timeline |
| Apogee Therapeutics, |
| Silence Therapeutics PLC |
Apogee Therapeutics, and Silence Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Apogee Therapeutics, and Silence Therapeutics
The main advantage of trading using opposite Apogee Therapeutics, and Silence Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apogee Therapeutics, position performs unexpectedly, Silence Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Silence Therapeutics will offset losses from the drop in Silence Therapeutics' long position.| Apogee Therapeutics, vs. Monster Beverage Corp | Apogee Therapeutics, vs. EvoAir Holdings | Apogee Therapeutics, vs. Brandywine Realty Trust | Apogee Therapeutics, vs. Western Digital |
| Silence Therapeutics vs. Tff Pharmaceuticals | Silence Therapeutics vs. Eliem Therapeutics | Silence Therapeutics vs. Inhibrx | Silence Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |